1-2 of 2
for the Cancer and Leukemia Group B
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Clinical Trials & Observations
Jonathan E. Kolitz, Stephen L. George, Guido Marcucci, Ravi Vij, Bayard L. Powell, Steven L. Allen, Daniel J. DeAngelo, Thomas C. Shea, Wendy Stock, Maria R. Baer, Vera Hars, Kati Maharry, Eva Hoke, James W. Vardiman, Clara D. Bloomfield, Richard A. Larson, for the Cancer and Leukemia Group B
Journal: Blood
Blood (2010) 116 (9): 1413–1421.
https://doi.org/10.1182/blood-2009-07-229492
Published: 2010
Journal Articles

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Clinical Trials & Observations
Mikkael A. Sekeres, Bercedis Peterson, Richard K. Dodge, Robert J. Mayer, Joseph O. Moore, Edward J. Lee, Jonathan Kolitz, Maria R. Baer, Charles A. Schiffer, Andrew J. Carroll, James W. Vardiman, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Richard M. Stone, for the Cancer and Leukemia Group B (CALGB)
Journal: Blood
Blood (2004) 103 (11): 4036–4042.
https://doi.org/10.1182/blood-2003-09-3118
Published: 2004